Anti-VEGF monotherapy treatment strategies for neovascular AMD

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.

Original languageEnglish (US)
Title of host publicationStudies on Retinal and Choroidal Disorders
PublisherHumana Press Inc.
Pages479-499
Number of pages21
ISBN (Electronic)9781617796067
ISBN (Print)9781617796050
DOIs
StatePublished - Jan 1 2012

Fingerprint

Vascular Endothelial Growth Factor A
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Kovach, J., Schwartz, S., Flynn, H. W., & Scott, I. U. (2012). Anti-VEGF monotherapy treatment strategies for neovascular AMD. In Studies on Retinal and Choroidal Disorders (pp. 479-499). Humana Press Inc.. https://doi.org/10.1007/978-1-61779-606-7_23

Anti-VEGF monotherapy treatment strategies for neovascular AMD. / Kovach, Jaclyn; Schwartz, Stephen; Flynn, Harry W; Scott, Ingrid U.

Studies on Retinal and Choroidal Disorders. Humana Press Inc., 2012. p. 479-499.

Research output: Chapter in Book/Report/Conference proceedingChapter

Kovach, J, Schwartz, S, Flynn, HW & Scott, IU 2012, Anti-VEGF monotherapy treatment strategies for neovascular AMD. in Studies on Retinal and Choroidal Disorders. Humana Press Inc., pp. 479-499. https://doi.org/10.1007/978-1-61779-606-7_23
Kovach J, Schwartz S, Flynn HW, Scott IU. Anti-VEGF monotherapy treatment strategies for neovascular AMD. In Studies on Retinal and Choroidal Disorders. Humana Press Inc. 2012. p. 479-499 https://doi.org/10.1007/978-1-61779-606-7_23
Kovach, Jaclyn ; Schwartz, Stephen ; Flynn, Harry W ; Scott, Ingrid U. / Anti-VEGF monotherapy treatment strategies for neovascular AMD. Studies on Retinal and Choroidal Disorders. Humana Press Inc., 2012. pp. 479-499
@inbook{463cfd464e7f4bd0b71de1f5b2a7f572,
title = "Anti-VEGF monotherapy treatment strategies for neovascular AMD",
abstract = "This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.",
author = "Jaclyn Kovach and Stephen Schwartz and Flynn, {Harry W} and Scott, {Ingrid U.}",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-1-61779-606-7_23",
language = "English (US)",
isbn = "9781617796050",
pages = "479--499",
booktitle = "Studies on Retinal and Choroidal Disorders",
publisher = "Humana Press Inc.",

}

TY - CHAP

T1 - Anti-VEGF monotherapy treatment strategies for neovascular AMD

AU - Kovach, Jaclyn

AU - Schwartz, Stephen

AU - Flynn, Harry W

AU - Scott, Ingrid U.

PY - 2012/1/1

Y1 - 2012/1/1

N2 - This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.

AB - This chapter provides a review of the discovery of anti-vascular endothelial growth factor (VEGF) agents, the evolution of drug development, and the refinement of evidence-based treatment strategies for neovascular AMD.

UR - http://www.scopus.com/inward/record.url?scp=85027317395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027317395&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-606-7_23

DO - 10.1007/978-1-61779-606-7_23

M3 - Chapter

AN - SCOPUS:85027317395

SN - 9781617796050

SP - 479

EP - 499

BT - Studies on Retinal and Choroidal Disorders

PB - Humana Press Inc.

ER -